Cell Therapy Technologies Market Report 2021-2031

細胞治療技術の世界市場2021年-2031年

◆タイトル:Cell Therapy Technologies Market Report 2021-2031
◆商品コード:VGA21MA014
◆調査・発行会社:visiongain
◆発行日:2021年3月
◆ページ数:314
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用、1年間、印刷不可)USD4,549 ⇒換算¥0見積依頼/購入/質問フォーム
Global Site License(法人閲覧用、1年間、印刷可)USD9,099 ⇒換算¥0見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、世界の細胞治療技術の市場について調査・分析し、レポート概要、エグゼクティブサマリー、産業インサイト、製品別(消耗品、機器、システム・ソフトウェア)分析、細胞種類別(T細胞、幹細胞、その他細胞)分析、プロセス別(細胞処理、細胞保存・流通・ハンドリング、プロセス監視・品質管理)分析、エンドユーザー別(バイオ医薬品・バイオテクノロジー企業・CRO、研究機関・セルバンク)分析、地域別分析、企業情報などの項目を掲載しています。
・レポート概要
・エグゼクティブサマリー
・産業インサイト
・世界の細胞治療技術市場規模:製品別(消耗品、機器、システム・ソフトウェア)
・世界の細胞治療技術市場規模:細胞種類別(T細胞、幹細胞、その他細胞)
・世界の細胞治療技術市場規模:プロセス別(細胞処理、細胞保存・流通・ハンドリング、プロセス監視・品質管理)
・世界の細胞治療技術市場規模:エンドユーザー別(バイオ医薬品・バイオテクノロジー企業・CRO、研究機関・セルバンク)
・世界の細胞治療技術市場規模:地域別
・企業情報

Growing Focus on Precision Medicine to Offer Lucrative Growth Opportunities Over the Next Decade

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burden and the need for more personalized & precision medicine has led to massive growth in the cell therapy technologies market, which is likely to increase over the next decade. While the global market will experience significant growth, the Asia Pacific region is expected to be the fastest growing submarket, primarily due to the presence of large numbers of clinical research organizations (CROs) in the region.

Technological Advancements Anticipated to Fuel Cell Therapy Technologies Market

Cell therapy technology is one of the fastest growing markets and is an ever-changing landscape. It represents the umbrella of recent advancement in the field of gene therapy, drug delivery, cancer vaccines, various application of stem cells, regenerative medicine, and tissue engineering. Higher government investments for cell-based research, availability of advanced cell therapy technologies and growing demand of cell therapies are expected to further propel the market growth.

UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

Which Factors are Fuelling Cell Therapy Technologies Industry Growth?
• Rising incidence of chronic & infectious diseases
• Large number of oncology-related cell therapy clinical trials
• Increasing GMP certifications for cell therapy production facilities
• Rising government initiatives towards cell-based research activities
Which Factors are Restraining Growth?
• Dearth of skilled professionals
• High cost of cell-based research & low success rate
What are the Market Opportunities?
• Increasing public-private partnerships for the development of cell therapies
• Emergence of iPSCs as an alternative to ESCs
• Emerging economies across Asia Pacific region
How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.

Discover how to stay ahead

Our 310+ page report provides 310+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cell Therapy Technologies Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and submarkets

Product
• Consumables
• Equipment
• Systems & Software
Cell Type
• T-Cells
• Stem Cells
• Other Cells
Process
• Cell Processing
• Cell Preservation, Distribution, and Handling
• Process Monitoring and Quality Control
End-User
• Biopharmaceutical & Biotechnology Companies
• CROs, Research Institutes and Cell Banks
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:

By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• Rest of Asia Pacific
• Rest of the World
• Brazil
• Mexico
• GCC
• Rest of RoW

【レポートの目次】

1 Report Overview
1.1 Introduction to Cell Therapy Technologies Market
1.2 Cell Therapy Technologies Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Industry Insights
3.1 Drivers
3.1.1 Rising incidence of chronic and infectious diseases
3.1.2 Large number of oncology-related cell therapy clinical trials
3.1.3 Increasing GMP certifications for cell therapy production facilities
3.2 Restraints
3.2.1 High cost of cell-based research and low success rate
3.2.2 Dearth of skilled professionals
3.3 Opportunities
3.3.1 Increasing public-private partnerships for the development of cell therapies
3.3.2 Emerging economies across Asia Pacific
3.3.3 Emergence of iPSCs as an alternative to ESCs
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Industry analysis – Porter’s
3.5.1 Buyer Power (Moderate-to-High)
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 Industry analysis – PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
4 Cell Therapy Technologies Market by Product,2021-2031
4.1 Consumables Segment Market Forecast, 2021-2031
4.1.1 Recovery Scenarios (V, U, W, L)
4.2 Equipment Segment Market Forecast, 2021-2031
4.2.1 Recovery Scenarios (V, U, W, L)
4.3 Systems & Software Segment Market Forecast, 2021-2031
4.3.1 Recovery Scenarios (V, U, W, L)
5 Cell Therapy Technologies Market by Cell Type,2021-2031
5.1 T-Cells Segment Market Forecast, 2021-2031
5.1.1 Recovery Scenarios (V, U, W, L)
5.2 Stem Cells Segment Market Forecast, 2021-2031
5.2.1 Recovery Scenarios (V, U, W, L)
5.3 Other Cells Segment Market Forecast, 2021-2031
5.3.1 Recovery Scenarios (V, U, W, L)
6 Cell Therapy Technologies Market by Process,2021-2031
6.1 Cell Processing Segment Market Forecast, 2021-2031
6.1.1 Recovery Scenarios (V, U, W, L)
6.2 Cell Preservation, Distribution, and Handling Segment Market Forecast, 2021-2031
6.2.1 Recovery Scenarios (V, U, W, L)
6.3 Process Monitoring and Quality Control Segment Market Forecast, 2021-2031
6.3.1 Recovery Scenarios (V, U, W, L)
7 Cell Therapy Technologies Market by End-User
7.1 Biopharmaceutical & Biotechnology Companies and CROs Segment Market Forecast, 2021-2031
7.1.1 Recovery Scenarios (V, U, W, L)
7.2 Research Institutes and Cell Banks Segment Market Forecast, 2021-2031
7.2.1 Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Cell Therapy Technologies Market Forecasts 2021-2031
8.1 Global Cell Therapy Technologies Market by Region Forecast 2021-2031
8.2 Recovery Scenarios (V, U, W, L)
9 North America Cell Therapy Technologies Market
9.1 North America Currently Dominates the Global Cell Therapy Technologies Market
9.2 North America Cell Therapy Technologies Market by Country, Forecast 2021-2031
9.3 North America Cell Therapy Technologies Market Forecast by Product
9.4 North America Cell Therapy Technologies Market Forecast by Cell Type
9.5 North America Cell Therapy Technologies Market Forecast by Process
9.6 North America Cell Therapy Technologies Market Forecast by End-User
9.7 U.S. Cell Therapy Technologies Market Forecast, 2021-2031
9.7.1 U.S. Dominates the North American Cell Therapy Technologies Market
9.7.2 Recovery Scenarios (V, U, W, L): U.S. Cell Therapy Technologies Market Forecast, 2021-2031
9.8 Canada Cell Therapy Technologies Market Forecast, 2021-2031
9.8.1 Growing Partnerships Among Research Entities to Fuel Regional Growth Through 2031
9.8.2 Recovery Scenarios (V, U, W, L): Canada Cell Therapy Technologies Market Forecast, 2021-2031
10 Europe Cell Therapy Technologies Market
10.1 Europe is Second Largest Cell Therapy Technologies Market Globally
10.2 Europe Cell Therapy Technologies Market by Country, Forecast 2021-2031
10.3 Europe Cell Therapy Technologies Market Forecast by Product
10.4 Europe Cell Therapy Technologies Market Forecast by Cell Type
10.5 Europe Cell Therapy Technologies Market Forecast by Process
10.6 Europe Cell Therapy Technologies Market Forecast by End-User
10.7 Germany Cell Therapy Technologies Market Forecast, 2021-2031
10.7.1 Germany Cell Therapy Technologies to Witness Highest Growth Across the European Region
10.7.2 Recovery Scenarios (V, U, W, L): Germany Cell Therapy Technologies Market Forecast, 2021-2031
10.8 UK Cell Therapy Technologies Market Forecast, 2021-2031
10.8.1 Collaborations Among Research Institutes to Boost UK Cell Therapy Technologies Market Growth
10.8.2 Recovery Scenarios (V, U, W, L): UK Cell Therapy Technologies Market Forecast, 2021-2031
10.9 France Cell Therapy Technologies Market Forecast, 2021-2031
10.9.1 French Cell Therapy Technologies Industry Anticipated to Offer Competitive Therapies Over the Next Decade
10.9.2 Recovery Scenarios (V, U, W, L): France Cell Therapy Technologies Market Forecast, 2021-2031
10.10 Italy Cell Therapy Technologies Market Forecast, 2021-2031
10.10.1 Support from Biomedical Institutions to Fuel Italian Cell Therapy Technologies Market
10.10.2 Recovery Scenarios (V, U, W, L): Italy Cell Therapy Technologies Market Forecast, 2021-2031
10.11 Spain Cell Therapy Technologies Market Forecast, 2021-2031
10.11.1 Spanish Cell Therapy Technologies Accounts for Significant Share Across the European Region
10.11.2 Recovery Scenarios (V, U, W, L): Spain Cell Therapy Technologies Market Forecast, 2021-2031
10.12 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031
10.12.1 Recovery Scenarios (V, U, W, L): Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031
11 Asia Pacific Cell Therapy Technologies Market
11.1 Asia Pacific Cell Therapy Technologies to Witness Highest Growth Rate from 2021 to 2031
11.2 Asia Pacific Cell Therapy Technologies Market by Country, Forecast 2021-2031
11.3 Asia Pacific Cell Therapy Technologies Market Forecast by Product
11.4 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type
11.5 Asia Pacific Cell Therapy Technologies Market Forecast by Process
11.6 Asia Pacific Cell Therapy Technologies Market Forecast by End-User
11.7 Japan Cell Therapy Technologies Market Forecast, 2021-2031
11.7.1 Japanese Cell Therapy Technologies is Second Largest Market in Asia Pacific Region
11.7.2 Recovery Scenarios (V, U, W, L): Japan Cell Therapy Technologies Market Forecast, 2021-2031
11.8 China Cell Therapy Technologies Market Forecast, 2021-2031
11.8.1 China Currently Dominates the Asia Pacific Cell Therapy Technologies Market
11.8.2 Recovery Scenarios (V, U, W, L): China Cell Therapy Technologies Market Forecast, 2021-2031
11.9 India Cell Therapy Technologies Market Forecast, 2021-2031
11.9.1 Indian Cell Therapy Technologies Anticipated to Witness Highest Growth Rate from 2021 to 2031
11.9.2 Recovery Scenarios (V, U, W, L): India Cell Therapy Technologies Market Forecast, 2021-2031
11.10 Australia Cell Therapy Technologies Market Forecast, 2021-2031
11.10.1 Developing Global Capabilities Will Accelerate Regional Cell Therapy Technologies by 2031
11.10.2 Recovery Scenarios (V, U, W, L): Australia Cell Therapy Technologies Market Forecast, 2021-2031
11.11 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031
11.11.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031
12 RoW Cell Therapy Technologies Market
12.1 RoW Cell Therapy Technologies Market Being Driven by Brazilian Economy
12.2 Recovery Scenarios (V, U, W, L)
12.3 RoW Cell Therapy Technologies Market Forecast by Product
12.4 RoW Cell Therapy Technologies Market Forecast by Cell Type
12.5 RoW Cell Therapy Technologies Market Forecast by Process
12.6 RoW Cell Therapy Technologies Market Forecast by End-User
12.7 Brazil Cell Therapy Technologies Market Forecast, 2021-2031
12.7.1 Brazil Currently Dominates the RoW Cell Therapy Technologies Market
12.7.2 Recovery Scenarios (V, U, W, L): Brazil Cell Therapy Technologies Market Forecast, 2021-2031
12.8 Mexico Cell Therapy Technologies Market Forecast, 2021-2031
12.8.1 Mexican Cell Therapy Technologies to Offer Lucrative Growth Opportunities Through 2031
12.8.2 Recovery Scenarios (V, U, W, L): Mexico Cell Therapy Technologies Market Forecast, 2021-2031
12.9 GCC Cell Therapy Technologies Market Forecast, 2021-2031
12.9.1 Growing Research & Development to Fuel GCC Cell Therapy Technologies Market
12.9.2 Recovery Scenarios (V, U, W, L): GCC Cell Therapy Technologies Market Forecast, 2021-2031
12.10 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031
12.10.1 Recovery Scenarios (V, U, W, L): Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031
13 Company Profiles
13.1 Thermo Fisher Scientific
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis, 2015-2019
13.1.4 Product Benchmarking
13.1.5 Recent Developments
13.2 Merck KGaA
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 First Company to Make Acoustic Technology Available for Cell Therapy Manufacturing
13.2.4 Financial Analysis, 2015-2019
13.2.5 Product Benchmarking
13.2.6 Recent Developments
13.3 Lonza
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Manufacturing Agreement: Mesoblast and Lonza
13.3.4 Financial Analysis, 2015-2019
13.3.5 Product Benchmarking
13.3.6 Recent Developments
13.4 Danaher
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis, 2015-2019
13.4.4 Product Benchmarking
13.5 STEMCELL Technologies Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 Sartorius AG
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis, 2015-2019
13.6.4 Product Benchmarking
13.6.5 Recent Developments
13.7 TERUMO BCT, INC.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis, 2015-2019
13.7.4 Product Benchmarking
13.7.5 Recent Developments
13.8 Fresenius Medical Care AG & Co. KGaA
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis, 2015-2019
13.8.4 Product Benchmarking
13.8.5 Recent Developments
13.9 Avantor, Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.4 Services Benchmarking
13.9.5 Recent Developments
13.10 BD
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis, 2015-2019
13.10.4 Product Benchmarking
13.10.5 Recent Developments
13.11 CellGenix GmbH
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Recent Developments
13.12 Sirion-Biotech GmbH
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Recent Developments
14 Conclusion
14.1 Concluding Remarks
14.2 Recommendations for Market Players
14.3 Asia Pacific Cell Therapy Technologies Anticipated to Offer Lucrative Growth Opportunities Through 2031



★調査レポート[細胞治療技術の世界市場2021年-2031年] ( Cell Therapy Technologies Market Report 2021-2031 / VGA21MA014) 販売に関する免責事項
[細胞治療技術の世界市場2021年-2031年] ( Cell Therapy Technologies Market Report 2021-2031 / VGA21MA014) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆